Document Detail


Audit of the use of calcium carbonate as a phosphate binder in 100 patients treated with continuous ambulatory peritoneal dialysis.
MedLine Citation:
PMID:  1323075     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We studied the effect of converting 100 established CAPD patients from aluminium- to calcium-based phosphate binders. After a follow-up of 1 year only 60% of patients remained on calcium carbonate. Hypercalcaemia was the major problem, with more than 40% of patients having a serum calcium in excess of 3.0 mmol/l. Several patients required hospitalization for symptomatic hypercalcaemia. Hypercalcaemia was more common in patients with normal serum parathyroid hormone concentrations (65 versus 25%, P less than 0.01). Serum phosphate control was better prior to commencing calcium carbonate when patients were treated with aluminium phosphate binders mean 1.71 +/- 0.15 mmol/l (SEM) than at the time of maximum serum calcium concentration, 1.81 +/- 0.25, P less than 0.05. This study does not confirm the findings of others, which have suggested that calcium carbonate is a safe and effective phosphate binder for patients with end-stage renal failure.
Authors:
A Davenport; S Goel; J C MacKenzie
Related Documents :
1442775 - Catheter-related factors and peritonitis risk in capd patients.
17369715 - Diet therapy in patients receiving peritoneal dialysis.
16686285 - Streptococcus viridans-associated peritonitis after gastroscopy.
7081575 - Bacteria and septic complications in patients with perforated duodenal ulcers.
21414665 - A case for immediate-release niacin.
21972485 - Skin prick test reactivity to aeroallergens in jordanian allergic rhinitis patients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  7     ISSN:  0931-0509     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  1992  
Date Detail:
Created Date:  1992-09-10     Completed Date:  1992-09-10     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  632-5     Citation Subset:  IM    
Affiliation:
Department of Renal Medicine, Southmead Hospital, Bristol, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Alkaline Phosphatase / blood
Calcium / blood
Calcium Carbonate / pharmacology*
Female
Humans
Hypercalcemia / etiology
Male
Middle Aged
Peritoneal Dialysis, Continuous Ambulatory*
Phosphates / metabolism*
Chemical
Reg. No./Substance:
0/Phosphates; 471-34-1/Calcium Carbonate; 7440-70-2/Calcium; EC 3.1.3.1/Alkaline Phosphatase
Comments/Corrections
Comment In:
Nephrol Dial Transplant. 1993;8(2):188-9   [PMID:  8384346 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Peritoneal drainage: an important element in host defence against staphylococcal peritonitis in pati...
Next Document:  Diabetic glomerulosclerosis without diabetes mellitus--two case reports and a review of the literatu...